Substituted estratrien derivatives as 17beta HSD inhibitors

Details for Australian Patent Application No. 2007327653 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Koskimies, Pasi; Messinger, Josef; Schoen, Uwe; Thole, Heinrich-Hubert; Husen, Bettina; Unkila, Mikko

Agent Watermark

Pub. Number AU-A-2007327653

PCT Pub. Number WO2008/065100

Priority 06125138.5 30.11.06 EP

Filing date 27 November 2007

Wipo publication date 5 June 2008

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/566 (2006.01) - having an oxo group in position 17, e.g. oestrone

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

C07J 43/00 (2006.01) Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

C07J 51/00 (2006.01) Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/065100 Priority application(s): WO2008/065100

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007327678-Hinged lid container with outer shell

2007327621-Substituted dihydroimidazoles and their use in the treatment of tumors